New Respiratory Infection Tests Pose Challenges To FDA, Industry
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics that quickly identify respiratory viral infections could help curb antibiotic abuse, but getting new tests to market will require a closer meeting of the minds between FDA and industry